Skip to main content Skip to main navigation menu Skip to site footer

Albumin and leukocyte: pre-operative factors for advanced management in pleural empyema?

  • Yopie Afriandi Habibie ,
  • Khalis Hamdani ,


Background: Surgical intervention such as video-assisted thoracoscopic surgery (VATS) has shown the benefit of reducing morbidity and mortality in the management of pleural empyema. The objective of the study was to investigate preoperative factors that could predict the need for VATS rather than chest tube thoracostomy.

Methods: This is retrospective observational study of consecutive patients diagnosed with pleural empyema admitted to the Dr. Zainoel Abidin Hospital, Banda Aceh in period of 2015 to 2017. The demographic, clinical dan laboratory data of the patients were evaluated from hospital medical records.

Results: A total of 48 consecutive patients were identified. The mean age of the patients was 34.3 ± 20.4 years; and 31 (64.6%) were male. Twenty-six patients underwent VATS decortication and twenty-two patients underwent chest tube thoracostomy. Patient demographics were similar between VATS decortication and chest tube thoracostomy group. The significant preoperative factors associated with the VATS were serum albumin level and leukocytes (p <0.05). The mean serum albumin level was 2.81 ± 0.44 g/dL for the VATS decortication group vs 3.06 ± 0.41 g/dL for the chest tube thoracostomy group (p = 0.047). In addition, serum leukocyte level was higher in VATS decortication group compared to chest tube thoracostomy group (21,600 mm-3 vs 12,900 mm-3; p = 0.024).

Conclusion: We demonstrate that a low serum albumin level or an elevated leukocyte level may represent as preoperative factors in which surgical treatment may be required in the management of pleural empyema.


  1. Rosenstengel A. Pleural infection-current diagnosis and management. J Thorac Dis. 2012;4(2):186–93.
  2. Bedawi EO, Hassan M, Rahman NM. Recent developments in the management of pleural infection: a comprehensive review. Clin Respir J. 2018;2:0–2.
  3. Scarci M, Abah U, Solli P, Page A, Waller D, van Schil P, et al. EACTS expert consensus statement for surgical management of pleural empyema. Eur J Cardio-thoracic Surg. 2015;48(5):642–53.
  4. Muhammad MIA. Management of complicated parapneumonic effusion and empyema using different treatment modalities. Asian Cardiovasc Thorac Ann. 2012;20(2):177–81.
  5. Chung JH, Lee SH, Kim KT, Jung JS, Son HS, Sun K. Optimal timing of thoracoscopic drainage and decortication for empyema. Ann Thorac Surg. 2014;97(1):224–9.
  6. Pan H, He J, Shen J, Jiang L, Liang W, He J. A meta-analysis of video-assisted thoracoscopic decortication versus open thoracotomy decortication for patients with empyema. J Thorac Dis. 2017;9(7):2006–14.
  7. Chalmers JD, Singanayagam A, Murray MP, Scally C, Hill AT. Risk Factors For Complicated Parapneumonic Effusion And Empyema On Presentation To Hospital With Community Acquired Pneumonia. Thorax. 2009;64(7):529-7.
  8. Schneider CR, Gauderer ML, Blackhurst D, Chandler JC, Abrams RS. Video-assisted thoracoscopic surgery as a primary intervention in pediatric parapneumonic effusion and empyema. Am Surg. 2010;76(9):957–61.
  9. Reichert M, Pösentrup B, Hecker A, Schneck E, Pons-Kühnemann J, Augustin F, et al. Thoracotomy versus video-assisted thoracoscopic surgery (VATS) in stage III empyema—an analysis of 217 consecutive patients. Surg Endosc Other Interv Tech. 2018;32(6):2664–75.
  10. Elsayed HH, Mostafa A, Fathy E, Diab HS, Nofal IM, Abdel Hamid OA, et al. Thoracoscopic management of early stages of empyema: is this the golden standard? J Vis Surg. 2018;4:114–114.
  11. Luh SP, Chou MC, Wang LS, Chen JY, Tsai TP. Video-assisted thoracoscopic surgery in the treatment of complicated parapneumonic effusions or empyemas: Outcome of 234 patients. Chest J. 2005;127(4):1427–32.
  12. Wozniak CJ, Paull DE, Moezzi JE, Scott RP, Anstadt MP, York VV, et al. Choice of First Intervention is Related to Outcomes in the Management of Empyema. Ann Thorac Surg. 2009;87(5):1525–31.
  13. Lardinois D, Gock M, Pezzetta E, Buchli C, Rousson V, Furrer M, et al. Delayed referral and gram-negative organisms increase the conversion thoracotomy rate in patients undergoing video-assisted thoracoscopic surgery for empyema. Ann Thorac Surg. 2005;79(6):1851–6.
  14. Semenkovich TR, Olsen MA, Puri V, Meyers BF, Kozower BD. Current State of Empyema Management. Ann Thorac Surg. 2018;105(6):1589–96.
  15. Kim SK, Kang CU, Song SH, Cho DG, Cho K Do, Kim CH. Factors predictive of the failure of medical treatment in patients with pleural infection. Korean J Intern Med. 2014;29(5):603–12.
  16. Vaziri M, Abed O. Management of thoracic empyema: Review of 112 cases. Acta Med Iran. 2012;50(3):203–7.
  17. Falguera M, Carratalà J, Bielsa S, García-Vidal C, Ruiz-González A, Chica I, et al. Predictive factors, microbiology and outcome of patients with parapneumonic effusion. Eur Respir J. 2011;38(5):1173–9.
  18. Prais D, Kuzmenko E, Amir J, Harel L. Association of Hypoalbuminemia With the Presence and Size of Pleural Effusion in Children With Pneumonia. Pediatrics. 2008;121(3):e533–8.

How to Cite

Habibie, Y. A., & Hamdani, K. (2019). Albumin and leukocyte: pre-operative factors for advanced management in pleural empyema?. Bali Medical Journal, 8(3), 926–929.




Search Panel

Yopie Afriandi Habibie
Google Scholar
BMJ Journal

Khalis Hamdani
Google Scholar
BMJ Journal